In 2023, Jason Lettmann earned $487.62K in total compensation at ALX Oncology Holdings Inc., including $217.33K salary and $119.00K bonus. Most recently acquired 84,000 shares in Mar 2025. Currently holds stock worth $839.33K. 2+ years at the helm of ALX Oncology Holdings Inc..
Compensation History
Annual executive compensation data for Jason Lettmann, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$487.62K
Salary
$217.33K
Bonus
$119.00K
Other
$151.29K
Salary
$217.33KBoard Justification
The compensation program is designed to attract, engage, and retain executive officers while aligning their interests with those of stockholders through performance-based incentives.
Bonus
$119.00KBoard Justification
The annual target bonus for Mr. Lettmann was set at 55% of his annual base salary, prorated based on the number of days in 2023 during which he served as CEO.
Other Compensation
$151.29KBoard Justification
Includes $35,071 for board and committee service prior to his appointment as CEO and $116,219 for the non-employee director annual option award in June 2023.
Restricted Stock
Board Justification
No stock was reported as vested in 2023 for Mr. Lettmann.
Performance Metrics
The performance metrics for Mr. Lettmann's bonus were based entirely on corporate goals.
Jason Lettmann
CEO of ALX Oncology Holdings Inc.
Education
B.A. in Psychology from the University of Iowa and an M.B.A. from the University of Michigan's Ross School of Business
Field of Expertise
Business & Management
Sector of Economy
Healthcare
CEO of ALX Oncology Holdings Inc. for
2 years 3 months (Sep 2023 - Present)
Previous Experience
Partner at Morgenthaler Ventures, former CEO of Promedior Inc.
Other ALX Oncology Holdings Inc. CEOs
Holdings
Track Jason Lettmann's stock holdings and portfolio value over time.
Total Stock Sold
$12.24M
$12.24M
475,332 ALXO shares
What if they kept their stock?
If Jason Lettmann didn't sell their stock, today they would have:
Extra ALXO475,332 shares worth $674.97K.
This is -94.48% and $11.56M less than what they got when they sold the stock.
Insider Trading
Jason Lettmann's recent stock transactions, purchases, and sales filed with the SEC.
84,000 shares
ALXO
Mar 14, 2025
Received
$4.97K
ALXO at $1.15/share
Feb 19, 2025
Sale
$49.77K
ALXO at $11.31/share
Mar 14, 2024
Purchase
60,000 shares
ALXO
Feb 14, 2024
Received
$9.08M
ALXO at $27.91/share
Dec 13, 2021
Sale
$4.69M
ALXO at $32.17/share
Dec 8, 2021
Sale
$7.60M
ALXO at $19.00/share
Jul 21, 2020
Purchase
Rivals
Compare Jason Lettmann with competitor CEOs and industry peers.